WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	80,533	92,943	128,366	123,616	138,481	189,477
Market Cap Growth	-27.59%	-27.59%	3.84%	-10.73%	-26.91%	-
Enterprise Value	85,705	101,308	130,632	113,324	119,353	163,763
Last Close Price	6100.00	7040.00	9730.00	9270.64	10388.65	14147.75
PE Ratio	16.85	19.43	16.13	49.86	32.48	28.48
PS Ratio	0.78	0.91	1.60	1.91	2.41	3.55
PB Ratio	0.87	1.00	1.42	1.49	1.71	2.47
P/TBV Ratio	1.05	1.05	1.46	1.54	1.75	2.52
P/FCF Ratio	11.08	12.79	-	-	102.25	-
P/OCF Ratio	9.65	9.65	-	22.98	17.27	234.06
EV/Sales Ratio	0.83	0.99	1.63	1.75	2.08	3.07
EV/EBITDA Ratio	9.08	10.73	12.15	16.60	18.69	17.79
EV/EBIT Ratio	15.14	17.90	16.52	23.23	24.43	22.65
EV/FCF Ratio	11.79	13.94	-	-	88.13	-
Debt / Equity Ratio	0.26	0.26	0.22	0.26	0.29	0.22
Debt / EBITDA Ratio	2.55	2.55	1.86	3.14	3.62	1.87
Debt / FCF Ratio	3.31	3.31	-	-	17.06	-
Asset Turnover	0.77	0.77	0.64	0.54	0.51	-
Inventory Turnover	2.31	2.31	2.52	3.07	2.98	-
Quick Ratio	1.21	1.21	1.20	1.74	2.55	2.95
Current Ratio	1.80	1.80	1.88	2.33	3.19	3.64
Return on Equity (ROE)	5.22%	5.22%	9.19%	3.02%	5.41%	-
Return on Assets (ROA)	2.67%	2.67%	3.95%	2.56%	2.71%	-
Return on Capital (ROIC)	3.11%	3.11%	4.60%	2.92%	3.08%	-
Return on Capital Employed (ROCE)	5.60%	5.60%	7.90%	5.20%	5.10%	8.40%
Earnings Yield	5.94%	5.15%	6.20%	2.01%	3.08%	3.51%
FCF Yield	9.02%	7.82%	-9.38%	-8.05%	0.98%	-2.35%
Payout Ratio	27.57%	27.57%	-	25.53%	9.90%	54.19%
Buyback Yield / Dilution	-0.14%	-0.14%	-0.08%	0.09%	-59.55%	-6.63%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.